Comparison of outcomes in patients with versus without diabetes mellitus after revascularization with everolimus- and sirolimus-eluting stents (from the SORT OUT IV Trial)

American Journal of Cardiology

Volumn 110, Issue 11, 2012, Pages 1585-1591

  Jensen, Lisette Okkels ^a   Thayssen, Per ^a   Junker, Anders ^a   Maeng, Michael ^b   Tilsted, Hans Henrik ^b   Kaltoft, Anne ^b   Hansen, Knud Norregaard ^a   Christiansen, Evald Hoj ^b   Kristensen, Steen Dalby ^b   Ravkilde, Jan ^b   Madsen, Morten ^b   Sorensen, Henrik Toft ^b   Thuesen, Leif ^b   Lassen, Jens Flensted ^b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; RAPAMYCIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; HEART DEATH; HEART DISEASE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STENT THROMBOSIS; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY DISEASE; DENMARK; DIABETES MELLITUS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SIROLIMUS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84869085094     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.07.022     Document Type: Article

References (21)

1. L.O. Jensen, P. Thayssen, H.H. Tilsted, J. Ravkilde, A. Junker, H.S. Hansen, K.N. Hansen, K.E. Pedersen, H.T. Sorensen, L. Thuesen, J.F. Lassen Scandinavian Organization for Randomized Trials with Clinical Outcome SORT OUT IV Investigators Rationale and design of a randomized clinical comparison of everolimus-eluting (Xience V/Promus) and sirolimus-eluting (Cypher Select+) coronary stents in unselected patients with coronary heart disease Cardiology 116 2010 73 78
2. L.O. Jensen, P. Thayssen, H.S. Hansen, E.H. Christiansen, H.H. Tilsted, L.R. Krusell, A.B. Villadsen, A. Junker, K.N. Hansen, A. Kaltoft, M. Maeng, K.E. Pedersen, S.D. Kristensen, H.E. Botker, J. Ravkilde, R. Sanchez, J. Aaroe, M. Madsen, H.T. Sorensen, L. Thuesen, J.F. Lassen Scandinavian Organization for Randomized Trials With Clinical Outcome IV (SORT OUT IV) Investigators Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV) Circulation 125 2012 1246 1255
3. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, G.A. Van Es, P.G. Steg, M.A. Morel, L. Mauri, P. Vranckx, E. McFadden, A. Lansky, M. Hamon, M.W. Krucoff, P.W. Serruys Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
4. T.F. Andersen, M. Madsen, J. Jorgensen, L. Mellemkjoer, J.H. Olsen The Danish National Hospital Register A valuable source of data for modern health sciences Dan Med Bull 46 1999 263 268
5. M.E. Charlson, P. Pompei, K.L. Ales, C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
6. L.O. Jensen, M. Maeng, A. Kaltoft, P. Thayssen, H.H. Hansen, M. Bottcher, J.F. Lassen, L.R. Krussel, K. Rasmussen, K.N. Hansen, L. Pedersen, S.P. Johnsen, H.T. Soerensen, L. Thuesen Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions J Am Coll Cardiol 50 2007 463 470
7. K. Juel, K. Helweg-Larsen The Danish registers of causes of death Dan Med Bull 46 1999 354 357
8. L. Frank Epidemiology When an entire country is a cohort Science 287 2000 2398 2399
9. T.A. Gooley, W. Leisenring, J. Crowley, B.E. Storer Estimation of failure probabilities in the presence of competing risks: new representations of old estimators Stat Med 18 1999 695 706
10. S. Greenland Modeling and variable selection in epidemiologic analysis Am J Public Health 79 1989 340 349
11. M. Billinger, J. Beutler, K.R. Taghetchian, A. Remondino, P. Wenaweser, S. Cook, M. Togni, C. Seiler, C. Stettler, F.R. Eberli, T.F. Lüscher, S. Wandel, P. Jüni, B. Meier, S. Windecker Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients Eur Heart J 29 2008 718 725
12. A. Dibra, A. Kastrati, J. Mehilli, J. Pache, H. Schühlen, N. von Beckerath, K. Ulm, R. Wessely, J. Dirschinger, A. Schömig ISAR-DIABETES Study Investigators Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients N Engl J Med 353 2005 663 670
13. L.O. Jensen, M. Maeng, P. Thayssen, E.H. Christiansen, K.N. Hansen, A. Galloe, H. Kelbaek, J.F. Lassen, L. Thuesen Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: the randomized diabetes and drug-eluting Stent (DiabeDES) intravascular ultrasound trial Eur Heart J 29 2008 2733 2741
14. P. Jimenez-Quevedo, M. Sabate, D.J. Angiolillo, M.A. Costa, F. Alfonso, J.A. Gomez-Hospital, R. Hernandez-Antolin, C. Banuelos, J. Goicolea, F. Fernandez-Aviles, T. Bass, J. Escaned, R. Moreno, C. Fernandez, C. Macaya Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial J Am Coll Cardiol 47 2006 2172 2179
15. M. Maeng, L.O. Jensen, A.M. Galloe, P. Thayssen, E.H. Christiansen, K.N. Hansen, S. Helqvist, H.E. Botker, J.F. Lassen, L. Thuesen Comparison of the sirolimus-eluting versus paclitaxel-eluting coronary stent in patients with diabetes mellitus: the Diabetes and Drug-Eluting Stent (DiabeDES) randomized angiography trial Am J Cardiol 103 2009 345 349
16. M. Maeng, L.O. Jensen, H.H. Tilsted, A. Kaltoft, H. Kelbaek, U. Abildgaard, A. Villadsen, J. Aaroe, P. Thayssen, L.R. Krusell, E.H. Christiansen, H.E. Botker, S.D. Kristensen, J. Ravkilde, M. Madsen, H.T. Sorensen, K. Rasmussen, L. Thuesen, J.F. Lassen Outcome of sirolimus-eluting versus zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a SORT OUT III substudy) Am J Cardiol 108 2011 1232 1237
17. L.O. Jensen, M. Maeng, P. Thayssen, A. Villadsen, L. Krusell, H.E. Botker, K.E. Pedersen, J. Aaroe, E.H. Christiansen, T. Vesterlund, K.N. Hansen, J. Ravkilde, H.H. Tilsted, J.F. Lassen, L. Thuesen Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the Diabetes and Drug-Eluting Stent (DiabeDES III) angiography and intravascular ultrasound trial EuroIntervention 7 2011 323 331
18. W.J. Kim, S.W. Lee, S.W. Park, Y.H. Kim, S.C. Yun, J.Y. Lee, D.W. Park, S.J. Kang, C.W. Lee, J.H. Lee, S.W. Choi, I.W. Seong, B.K. Lee, N.H. Lee, Y.H. Cho, W.Y. Shin, S.J. Lee, S.W. Lee, M.S. Hyon, D.W. Bang, W.J. Park, H.S. Kim, J.K. Chae, K. Lee, H.K. Park, C.B. Park, S.G. Lee, M.K. Kim, K.H. Park, Y.J. Choi, S.S. Cheong, T.H. Yang, J.S. Jang, S.H. Her, S.J. Park ESSENCE-DIABETES Study Investigators Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trial Circulation 124 2011 886 892
19. R.A. Byrne, A. Kastrati, S. Massberg, A. Wieczorek, K.L. Laugwitz, M. Hadamitzky, S. Schulz, J. Pache, M. Fusaro, J. Hausleiter, A. Schömig, J. Mehilli ISAR-TEST 4 Investigators Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial J Am Coll Cardiol 58 2011 1325 1331
20. G.W. Stone, A. Rizvi, W. Newman, K. Mastali, J.C. Wang, R. Caputo, J. Doostzadeh, S. Cao, C.A. Simonton, K. Sudhir, A.J. Lansky, D.E. Cutlip, D.J. Kereiakes SPIRIT IV Investigators Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease N Engl J Med 362 2010 1663 1674
21. D.J. Kereiakes, D.E. Cutlip, R.J. Applegate, J. Wang, M. Yaqub, P. Sood, X. Su, G. Su, N. Farhat, A. Rizvi, C.A. Simonton, K. Sudhir, G.W. Stone Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) J Am Coll Cardiol 56 2010 2084 2089